{
    "0": 0,
    "% Lysis 30\u2009min (<7.5%)": 0,
    "1": 1,
    "18F FDG PET/CT indication": "18F FDG PET/CT indication",
    "2": 2,
    "2nd day after treatment": 2,
    "3": 3,
    "4th day after treatment": 3,
    "4": 4,
    "AAV treatment": 4,
    "5": 5,
    "Abdominal pain": 5,
    "6": 6,
    "ABG (pH)": 6,
    "ABG measured O2 saturation (%)": 6,
    "ABG partial pressure CO2 (mmHg)": 6,
    "ABG partial pressure O2 (mmHg)": 6,
    "7": 7,
    "ABO Rh": 7,
    "Blood type": 7,
    "8": 8,
    "Absolute reticulocyte count": 8,
    "Absolute lymphocyte count (\u00d7 109/L)": 8,
    "Absolute Lymphocyte Count (K/mm3)": 8,
    "Absolute Lymphocyte Count Address correspondence to(\u00d7 1000/\u00b5L)": 8,
    "Absolute lymphocyte count, cells/\u03bcL": 8,
    "Abs. lymphocyte count (1.0\u20134.8 K/mm3)": 8,
    "9": 9,
    "Absolute neutrophil count (\u00d7 109/L)": 9,
    "Absolute Neutrophil Count (K/mm3)": 9,
    "10": 10,
    "ACEI or ARB": 10,
    "11": 11,
    "Activated partial thromboplastin time": "Prothrombin time",
    "Activated partial thromboplastin time (27\u201339.2\u00a0s)": 11,
    "Activated partial thromboplastin time (APTT)": 11,
    "Activated partial- thromboplastin time (APTT) (0.85 \u2013 1.15 ratio)": 11,
    "Activated partial- thromboplastin time (aPTT) (20\u201335 s)": 11,
    "Activated partial thromboplastin time (s) RR < 1.2\u2009s": 11,
    "Activated partial thromboplastin time (s, 29.0~42.0)": 11,
    "Activated partial-thromboplastin time (APPT) (s)": 11,
    "Activated partial-thromboplastin time (sec)": 11,
    "12": 12,
    "Acute kidney injury": 12,
    "13": 13,
    "Acute on chronic liver failure": 13,
    "14": 14,
    "Acute treatment of stroke": 14,
    "15": 15,
    "Additional therapies": 15,
    "16": 16,
    "Adjuvant TMZ": 16,
    "17": 17,
    "Admission date": 17,
    "Admission to intensive care unit": 17,
    "18": 18,
    "Admission/ peak C-reactive protein (mg/dL)\u2021": "C-reactive protein, mg/dL",
    "19": 19,
    "Admission/ peak D dimer (ng/mL)\u2020": 19,
    "20": 20,
    "Admission/peak troponin-I (ng/mL)*": "Troponin I",
    "21": 21,
    "After termination of isoflurane (data after termination of isoflurane were collected in the first 30\u2009min after the change of volatile to IV sedation)": 21,
    "22": 22,
    "After treatment": 22,
    "23": 23,
    "Age": 23,
    "age": 23,
    "Age (y)": 23,
    "Age (years)": 23,
    "Age (yr)": 23,
    "Age (yr, mo)": 23,
    "Age (yrs)": 23,
    "Age in years": 23,
    "Age, y": 23,
    "Age, years": 23,
    "Age, yr": 23,
    "Patient age (years)": 23,
    "24": 24,
    "Age - year/ Sex": 24,
    "Age (sex)": 24,
    "Age (years)/sex": 24,
    "Age(y)/sex": 24,
    "Age(years)/Sex": 24,
    "Age, Gender": 24,
    "Sex/age, years": 24,
    "Patient/Sex/Age. yr": 24,
    "25": 25,
    "Air": "Oxygen therapy",
    "26": 26,
    "Alanine aminotransferase": 26,
    "Alanine aminotransferase (0\u201341\u00a0U/L)": 26,
    "Alanine aminotransferase (8- 40\u2009U/L)": 26,
    "Alanine aminotransferase (ALT)": 26,
    "Alanine aminotransferase (ALT) (U/L)": 26,
    "Alanine aminotransferase (u/L)": 26,
    "Alanine aminotransferase (U/L)": 26,
    "Alanine aminotransferase (U/L, \u2264\u200941)": 26,
    "Alanine aminotransferase ALT (4\u201345 IU/L)": 26,
    "Alanine aminotransferase, IU/L": 26,
    "Alanine aminotransferase, U/L": 26,
    "ALAT (IU/L)": 26,
    "ALT": 26,
    "ALT (IU/L)": 26,
    "ALT (U/l)": 26,
    "ALT (U/L)": 26,
    "ALT (UI/L)": 26,
    "ALT, 14-67 U/L": 26,
    "ALT, U/L": 26,
    "ALT, U/L [range: 00\u201355]": 26,
    "27": 27,
    "Albumin": 27,
    "Albumin (3.5\u20135.2\u00a0g/dL)": 27,
    "Albumin (3\u20135\u00a0\u200bg/dL)": 27,
    "Albumin (g/dL)": 27,
    "Albumin (g/L)": 27,
    "Albumin (g/L, 35~52)": 27,
    "Albumin, g/dL": 27,
    "ALK.P IU/L Male: 0\u2013270": 27,
    "Alkaline phosphatase": 27,
    "Alkaline phosphatase (IU/L)": 27,
    "Alkaline phosphatase (IU/l)": 27,
    "Alkaline phosphatase, U/L": 27,
    "ALP (IU/L)": 27,
    "ALP (U/L)": 27,
    "ALP, 38-150 U/L": 27,
    "28": 28,
    "Alpha angle (64\u00b0-80\u00b0)": 28,
    "29": 29,
    "Alpha-fetoprotein": 29,
    "30": 30,
    "AMI indexes": 30,
    "31": 31,
    "Ammonia concentration": 31,
    "32": 32,
    "Anaemia (Hb <8 g/dl)": 32,
    "33": 33,
    "Analgesia": 33,
    "34": 34,
    "Anion Gap (mmol/L)": 34,
    "35": 35,
    "Anorexia": "Clinical characteristics",
    "36": 36,
    "Antiarrhythmics": 36,
    "37": 37,
    "Antibiotic therapy": "Therapy",
    "Antibiotic treatment": 37,
    "38": 38,
    "Antibiotics used before onset of neurological symptoms": 38,
    "39": 39,
    "Antibody titers 2 wk after rituximab": "IgG anti-S1-S2\u00a0AU/ml",
    "40": 40,
    "Antibody titers on admission": "IgG anti-S1-S2\u00a0AU/ml",
    "41": 41,
    "Anti-cardiolipin antibody search": 41,
    "Anticoagulant therapy": 41,
    "Anticoagulation administered": 41,
    "42": 42,
    "Anticoagulation before thrombotic event": 42,
    "43": 43,
    "Anti-glycoprotein IIb/IIIa antibody search": 43,
    "44": 44,
    "Antinuclear antibody": 44,
    "Antinuclear factor search": 44,
    "45": 45,
    "Antioxidant therapy": 45,
    "46": 46,
    "Anti-PF4 antibody search": 46,
    "47": 47,
    "Antiphospholipid antibodies": 47,
    "Antiphospholipid antibodies:Anticardiolipin (aCL)Anti-\u03b22-glycoprotein-1 (a\u03b22GPI)": 47,
    "48": 48,
    "Antiphospholipid serology": 48,
    "49": 49,
    "Antiplatelet/anticoagulant": 49,
    "50": 50,
    "Anti-thrombin (IU/dL)": 50,
    "51": 51,
    "Antithrombotic treatment at time of ICH": 51,
    "52": 52,
    "Antiviral therapy": "Therapy",
    "Antiviral treatment": 52,
    "53": 53,
    "Anxiety, depression": 53,
    "54": 54,
    "Aortic thrombosis type": 54,
    "55": 55,
    "APACHE IV score": 55,
    "56": 56,
    "Approximate date after Covid-19 when stroke diagnosed": 56,
    "57": 57,
    "aPTT": "Prothrombin time",
    "APTT (26-44\u2009s)": 57,
    "APPT ratio": 57,
    "aPTT (27.0\u201337.7 sec)": 57,
    "APTT (s)": 57,
    "aPTT (sec)": 57,
    "aPTT seconds": 57,
    "aPTT, s": 57,
    "58": 58,
    "ARDS": 58,
    "59": 59,
    "Arterial blood gas (ABG)": 59,
    "60": 60,
    "Arterial event": 60,
    "61": 61,
    "ASAT (IU/L)": 61,
    "62": 62,
    "Ascites": 62,
    "63": 63,
    "ASO titer": 63,
    "64": 64,
    "Aspartate aminotransferase": 64,
    "Aspartate amino transferase (AST) (U/L)": 64,
    "Aspartate aminotransferase (0\u201341\u00a0U/L)": 64,
    "Aspartate aminotransferase (5 -40\u2009U/L)": 64,
    "Aspartate aminotransferase (AST)": 64,
    "Aspartate aminotransferase (U/L)": 64,
    "Aspartate aminotransferase (U/L) Alanine aminotransferase (U/L)": 64,
    "Aspartate aminotransferase (U/L, \u2264\u200940)": 64,
    "Aspartate aminotransferase , IU/L": 64,
    "Aspartate aminotransferase AST (15\u201341 IU/L)": 64,
    "Aspartate aminotransferase, U/L": 64,
    "Aspartate Transaminase (10 \u2013 50 IU/L)": 64,
    "AST": 64,
    "AST (IU/L)": 64,
    "AST (U/L)": 64,
    "AST (U/l)": 64,
    "AST (UI/L)": 64,
    "AST, 6-58 U/L": 64,
    "AST, U/L": 64,
    "AST, U/L [range: 05\u201334]": 64,
    "65": 65,
    "ATT": 65,
    "66": 66,
    "B lymphocyte immunophenotyping": 66,
    "67": 67,
    "Bacterial pneumonia": 67,
    "68": 68,
    "Baseline Respiratory Function": "Oxygen saturation",
    "69": 69,
    "Basic disease": 69,
    "70": 70,
    "Basophil": 70,
    "Basophils": 70,
    "Basophils (0.0\u20130.15 \u00d7 109/L)": 70,
    "71": 71,
    "Bicarbonate (mmol/dl)": 71,
    "Bicarbonate (mmol/L)": 71,
    "Bicarbonate, mEq/L": 71,
    "72": 72,
    "Bilateral or Unilateral Pneumothorax": 72,
    "73": 73,
    "Bilirubin (\u00b5mol/L)": 73,
    "Bilirubin (3 \u2013 20 umol/L)": 73,
    "Bilirubin, total (3\u201320 umol/L)": 73,
    "74": 74,
    "Birth weight": "\u0443\u0431\u0440\u0430\u0442\u044c",
    "75": 75,
    "Bloating": 75,
    "76": 76,
    "Blood biochemistry": 76,
    "77": 77,
    "Blood glucose (4.0\u20135.4 mmol/L)": "Blood glucose (4.0\u20135.4 mmol/L)",
    "78": 78,
    "Blood potassium (mmol/l)": 78,
    "79": 79,
    "Blood pressure (mm Hg)": "Blood pressure (mm Hg)",
    "80": 80,
    "Blood pressure (mm Hg) (at the time of ICH detection)": "Blood pressure (mm Hg)",
    "81": 81,
    "Blood routine": 81,
    "82": 82,
    "Blood sodium (mmol/l)": 82,
    "83": 83,
    "Blood sugar (mg/dl)": "Blood glucose (4.0\u20135.4 mmol/L)",
    "84": 84,
    "Blood urea (mg/dl)": "Blood urea nitrogen (mg/dL)",
    "85": 85,
    "Blood urea nitrogen (mg/dL)": 85,
    "Blood urea nitrogen (mg/dl)": 85,
    "Blood urea nitrogen (mmol/L)": 85,
    "86": 86,
    "BMI": 86,
    "BMI (kg/m2)": 86,
    "BMI (kg/m\u00b2)": 86,
    "BMI category": 86,
    "BMI in kg/m2": 86,
    "Body mass index (kg/m2)": 86,
    "Body mass index, kg/m2": 86,
    "Body mass index, kg/m2 (percentile)": 86,
    "87": 87,
    "BNP (ng/L)": 87,
    "BNP (0\u2013125 pg/mL)": 87,
    "BNP (pg/mL)": 87,
    "BNP (<300\u2009pg/ml)": 87,
    "88": 88,
    "Brain(online supplementary figures S1 and S2)": 88,
    "89": 89,
    "BUN": 89,
    "BUN (mg/dL)": 89,
    "BUN (mg/dl)": 89,
    "BUN mg/dl 7\u201316.8": 89,
    "90": 90,
    "C3 (mg/dL)": 90,
    "91": 91,
    "C4 (mg/dL)": 91,
    "92": 92,
    "Ca": 92,
    "Ca mg/dl 8.6\u201310.3": 92,
    "93": 93,
    "Cardiac troponin I (pg/mL, \u2264\u200934.2)": "Troponin I",
    "Cardiac Troponin T (<0.01\u00a0pg/ml)": 93,
    "94": 94,
    "Cardiomyopathy": 94,
    "95": 95,
    "Cardiovascular risk factors": 95,
    "96": 96,
    "CCP units transfused": 96,
    "97": 97,
    "Ceftriaxone dependent RBC antibody": 97,
    "98": 98,
    "Cerebrovascular Imaging": 98,
    "99": 99,
    "Chest": 99,
    "Chest CT": 99,
    "Chest CT evidence of pneumonia": 99,
    "100": 100,
    "Chest drain duration (days)": 100,
    "101": 101,
    "Chest tightness": 101,
    "102": 102,
    "Chest Tube": "Mechanical Ventilator Status",
    "103": 103,
    "Chest X ary finding": 103,
    "Chest X ray": 103,
    "Chest Radiologic Findings": 103,
    "Radiological findings": 103,
    "104": 104,
    "Chief complaint": 104,
    "105": 105,
    "Child\u2013Pugh class": 105,
    "106": 106,
    "Chinese patent medicine treatment": "Treatment",
    "107": 107,
    "Chloride (mmol/L)": 107,
    "108": 108,
    "Cholinesterase": 108,
    "109": 109,
    "Chronic MG treatment": 109,
    "110": 110,
    "Chronic renal disease": "Clinical characteristics",
    "111": 111,
    "CK (reference range 20-300 U/L)": "Creatine kinase",
    "CK (U/L)": 111,
    "112": 112,
    "ClCr, ml/min": 112,
    "113": 113,
    "Clinical characteristics": 113,
    "Clinical presentation": 113,
    "Clinical symptoms": 113,
    "Early symptoms": 113,
    "Clinical Findings": 113,
    "Clinical symptoms of ischaemic stroke": 113,
    "COVID-19 symptoms": 113,
    "COVID-19 Symptoms": 113,
    "COVID\u2009\u2212\u200919 characteristics": 113,
    "MG symptoms during COVID-19": 113,
    "Onset symptoms": 113,
    "Onset of COVID symptoms to VST symptoms": 113,
    "Onset of neurological symptoms": 113,
    "Neurological symptoms": 113,
    "Initial symptoms": 113,
    "Initial visit signs and symptoms of COVID-19": 113,
    "Gastrointestinal symptoms": 113,
    "Presented symptoms": 113,
    "Presenting Symptoms": 113,
    "Presenting Symptoms\u204e\u204e": 113,
    "Presentation of COVID-19": 113,
    "SARS-CoV-2-related symptoms": 113,
    "Symptoms": 113,
    "Symptoms at COVID-19 disease onset": 113,
    "Symptoms at onset": 113,
    "Symptoms at onset of disease": 113,
    "Symptoms reported": 113,
    "Symptomatic System": 113,
    "114": 114,
    "Clinical presentation Features of raised intracranial tension": "Clinical characteristics",
    "115": 115,
    "Clinical presentation Memory": "Clinical characteristics",
    "116": 116,
    "Clinical presentation Neurological deficit": 116,
    "117": 117,
    "Clinical presentation Sensorium": "Clinical characteristics",
    "118": 118,
    "Clinical probability of VTE according to Wells' criteria": 118,
    "119": 119,
    "Clinical progression of case": "Clinical characteristics",
    "120": 120,
    "Clonidine, \u00b5g kg\u20131 hr\u20131": 120,
    "121": 121,
    "CMV PCR": 121,
    "122": 122,
    "Coagulation": 122,
    "Coagulation function": 122,
    "Coagulation profile": 122,
    "123": 123,
    "Comorbidities": 123,
    "Co-infection": 123,
    "Coexisting disorders": 123,
    "Coexisting chronic conditions": 123,
    "Co-Morbidities": 123,
    "comorbidity": 123,
    "Comorbidity": 123,
    "Co-morbidity": 123,
    "Comorbidity & VTE risk factors": 123,
    "Cardiovascular comorbidities": 123,
    "Medical Comorbidities": 123,
    "Medical history": 123,
    "Medical History": 123,
    "Maternal comorbid conditions": 123,
    "Patient history": 123,
    "124": 124,
    "Complement C4 (g/L)": 124,
    "125": 125,
    "Complications": "Comorbidity",
    "Complications during hospitalization": 125,
    "126": 126,
    "Computed tomography with IV contrast": 126,
    "127": 127,
    "Concurrent TMZ": 127,
    "128": 128,
    "Confirmed date by real-time RT-PCR": 128,
    "129": 129,
    "Convalescent plasma therapy": 129,
    "130": 130,
    "Corticosteroids": 130,
    "131": 131,
    "Cough": 131,
    "132": 132,
    "COVID diagnosis": 132,
    "Diagnosis": 132,
    "Diagnosis of COVID-19 (positive RT-PCR)": 132,
    "SARSCoV-2 involvement": 132,
    "Covid-19": 132,
    "133": 133,
    "COVID-19 disease severity": 133,
    "Disease severity": 133,
    "Disease severity*": 133,
    "COVID-19 stage": 133,
    "Disease status": 133,
    "Condition": 133,
    "134": 134,
    "COVID-19 medication": 134,
    "COVID-19 treatment": 134,
    "Pharmacological treatment": 134,
    "Treatment": 134,
    "Treatment for COVID-19": 134,
    "Treatment of COVID": 134,
    "Initial treatment": 134,
    "SARS-CoV-2 treatment (days)": 134,
    "135": 135,
    "COVID-19 PCR follow up": 135,
    "136": 136,
    "CPK (UI/L)": "Creatine kinase",
    "CPK (units/L)": 136,
    "CPK U/L": 136,
    "137": 137,
    "Cr": "Creatinine mg/dl",
    "Cr mg/dl Female: 0.6\u20131.3\u00a0mg/dlMale: 0.8\u20131.3\u00a0mg/dl": 137,
    "Cr, 0.62-1.66 mg/dL": 137,
    "138": 138,
    "Cranial nerve involvement": 138,
    "139": 139,
    "C-reactive protein, mg/dL": 139,
    "CRP": 139,
    "CRP (<5\u00a0mg/L)": 139,
    "CRP (0.0\u20130.4 mg/dL)": 139,
    "CRP (0-8\u2009mg/L)": 139,
    "CRP (mg/dL)": 139,
    "CRP (mg/L)": 139,
    "CRP (normal 0\u201310 mg/L)": 139,
    "CRP (Qualitative)": 139,
    "CRP (reference range 0.0-0.7 mg/dL)": 139,
    "CRP levels (mg/L)": 139,
    "CRP mg/dL": 139,
    "CRP mg/l": 139,
    "CRP mg/L 0\u20136": 139,
    "CRP, mg/dL": 139,
    "CRP, mg/ml [range: <\u00a00.5]": 139,
    "C-reactive protein (<5 mg/L)": 139,
    "C-reactive protein (<8.0\u2009mg/L)": 139,
    "C-reactive protein (0.00\u20130.40\u00a0mg/dL)": 139,
    "C-reactive protein (CRP)": 139,
    "C-reactive protein (CRP) (mg/dL)": 139,
    "C-reactive protein (less than 10)": 139,
    "C-reactive protein (mg/L)": 139,
    "C-reactive protein (mg/L) RR <5\u2009mg/l": 139,
    "C-reactive protein (mg/L, <\u20091\u00a0mg/L)": 139,
    "C-reactive protein high sensitivity (mg/L)": 139,
    "C- reactive protein (0\u20135\u00a0mg/L)": 139,
    "High-sensitivity C-reactive protein (mg/L)": 139,
    "High-sensitivity C reactive protein (mg/L)": 139,
    "140": 140,
    "Creatinase isoenzyme (0\u201326\u2009U/L)": 140,
    "141": 141,
    "Creatine kinase": 141,
    "Creatine kinase (25-196\u2009U/ L)": 141,
    "Creatine kinase (49\u2013397 IU/L)": 141,
    "Creatine kinase (U/L)": 141,
    "Creatine kinase MB (CKMB) (ng/mL)": 141,
    "Creatine kinase, MB Form (ng/mL, \u2264\u20097.2)": 141,
    "142": 142,
    "Creatinine mg/dl": 142,
    "creatinine umol/l": 142,
    "Creatinine, mg/dL": 142,
    "Creatinine, mg/dl [range: 0.8\u20131.25]": 142,
    "Creatinine (0.6\u20131.3\u00a0\u200bmg/dL)": 142,
    "Creatinine (0.7\u20131.5\u00a0mg/dL)": 142,
    "Creatinine (0.80\u20131.30 mg/dL)": 142,
    "Creatinine (40-106umol/L)": 142,
    "Creatinine (45 \u2013 120 mmol/L)": 142,
    "Creatinine (45\u2013120 mmol/L)": 142,
    "Creatinine (mg/dL)": 142,
    "Creatinine (mmol/L)": 142,
    "Creatinine (reference range 0.7-1.5 mg/dL)": 142,
    "Creatinine (\u03bcmol/L)": 142,
    "Creatinine (\u03bcmol/L, 59~104)": 142,
    "143": 143,
    "Creatinine level corresponding to CK (reference range 0.7-1.5 mg/dL)": 143,
    "Creatinine level corresponding to CK (reference range 20-300 U/L)": 143,
    "144": 144,
    "CRRT": 144,
    "145": 145,
    "CSF": 145,
    "CSF results": 145,
    "146": 146,
    "CT": 146,
    "CT-Scan on second admission": 146,
    "Characteristics of Baseline CT Scan": 146,
    "147": 147,
    "CTV/MRV findings": 147,
    "148": 148,
    "CXR": "Chest X ray finding",
    "CXR on a second admission": 148,
    "149": 149,
    "Dark urine": 149,
    "150": 150,
    "DAT Anti-C3b, C3d": 150,
    "DAT Anti-C3d": 150,
    "151": 151,
    "DAT Anti-IgG": 151,
    "152": 152,
    "DAT Polyspecific": 152,
    "153": 153,
    "DAT Saline Control": 153,
    "154": 154,
    "Date at onset of symptoms": 154,
    "155": 155,
    "Day 1 with isoflurane sedation (data were collected at 4 am on the first day after isoflurane treatment began)": 155,
    "156": 156,
    "Day of illness": 156,
    "157": 157,
    "Day of second episode": 157,
    "158": 158,
    "Days from COVID-19 diagnosis to stroke onset": 158,
    "Days from COVID-19 symptom onset to ischaemic stroke symptom onset": 158,
    "159": 159,
    "Days from COVID-19 symptom onset to ICU admission": 159,
    "160": 160,
    "Days From COVID-19 Symptoms and HSA": "Duration of symptoms",
    "Days from onset to admission, days": 160,
    "161": 161,
    "Days from onset to using corticosteroid, days": 161,
    "162": 162,
    "Days from the onset of symptoms to the thromboembolic event": "History of thrombosis",
    "163": 163,
    "Days Hospitalized": "Hospital LOS",
    "164": 164,
    "Days ill before hospitalisation": 164,
    "165": 165,
    "Days of immune booster use": 165,
    "166": 166,
    "Days on intubation during the event": 166,
    "167": 167,
    "Days to readmission": 167,
    "168": 168,
    "D-Dimer": 168,
    "D-dimer": 168,
    "D-dimer (<400 ng/L)": 168,
    "D-Dimer (<500 ng/mL)": 168,
    "D-Dimer (<500\u2009ng/mL)": 168,
    "D-dimer (\u00b5g/L)": 168,
    "D-dimer (\u00b5g/L) Reference range (RR) < 500": 168,
    "D-dimer (\u00b5g/ml)": 168,
    "d-Dimer (\u00b5g/mL)": 168,
    "D-dimer (0-1\u2009mg/ml)": 168,
    "D-Dimer (0\u2013230\u00a0ng/mL)": 168,
    "D-dimer (0\u2013499 ng/mL)": 168,
    "D-dimer (0\u2013500 ng/mL)": 168,
    "D-dimer (0\u2013500 ugFEU/L)": 168,
    "D-dimer (FEU/ml)": 168,
    "D-dimer (mg/L)": 168,
    "d-Dimer (ng/mL)": 168,
    "D-dimer (ng/mL)": 168,
    "d-Dimer (ng/ml)": 168,
    "d-dimer (ng/mL)": 168,
    "D-dimer (reference range <0.5 \u00b5g/mL FEU)": 168,
    "D-dimer (\u03bcg/L)": 168,
    "D-dimer (\u03bcg/ml FEU, <\u20090.5)": 168,
    "D-dimer mcg/ml": 168,
    "D-Dimer mcg/mL": 168,
    "D-Dimer ng/ml": 168,
    "D-Dimer ug/ml": 168,
    "D-dimer(<0,5\u00a0mg/L FEU)": 168,
    "D-dimer, mg/L": 168,
    "D-Dimer, ng/mL": 168,
    "D-dimer, ng/mL": 168,
    "D-dimer, quantitative (\u03bcg/mLFEU)": 168,
    "D-DimerReference: <500 ng//ml": 168,
    "D-dimers": 168,
    "D- Dimer (ng/ml)": 168,
    "D-dimers (ng/mL)": 168,
    "169": 169,
    "Death": 169,
    "Discharge from hospital": 169,
    "Discharged to": 169,
    "Disposition and outcome": 169,
    "Estimated mortality": 169,
    "Fetal outcome": 169,
    "Follow-up and outcome": 169,
    "Maternal outcome": 169,
    "Diagnosis of fetal death": 169,
    "Outcome": 169,
    "Status at Discharge": 169,
    "Outcomes": 169,
    "Survival": 169,
    "170": 170,
    "Delivery details": 170,
    "171": 171,
    "Department at time of diagnosis of arterial thromboembolism": 171,
    "172": 172,
    "Dexamethasone": 172,
    "173": 173,
    "Dexmedetomidine, \u00b5g kg\u20131 hr\u20131": 173,
    "174": 174,
    "Diabetes mellitus": 174,
    "175": 175,
    "Diagnosis of arterial thromboembolism": 175,
    "176": 176,
    "Diagnostic evidence for COVID-19 (diagnosis of COVID-19 infection was based on positivity of reverse transcription polymerase chain reaction (RT-PCR) or serology or computed tomography (CT) scan showing typical lesions)": "COVID-19 disease severity",
    "177": 177,
    "Dialysis": 177,
    "178": 178,
    "Diarrhea": 178,
    "179": 179,
    "DIC-score (ISTH)": 179,
    "180": 180,
    "Differential Count": 180,
    "Differential count (/mm3)": 180,
    "Differential count (per mm3) Total neutrophils Total lymphocytes Total monocytes": 180,
    "181": 181,
    "Digital subtraction angiography (DSA)": 181,
    "182": 182,
    "Direct bilirubin": "Total bilirubin",
    "Direct bilirubin (0\u20136.8umol/ L)": 182,
    "Direct bilirubin (\u03bcmol/L)": 182,
    "Direct bilirubin, mg/dL": 182,
    "183": 183,
    "Diuretic use at home": "Medications",
    "Diuretic use in the hospital": 183,
    "184": 184,
    "Dizziness": "Fatigue",
    "185": 185,
    "Drinking history": 185,
    "186": 186,
    "Duration of immobilization (days)": 186,
    "187": 187,
    "Duration of symptoms": "Duration of symptoms",
    "Duration of symptoms before diagnosis of VTE (days)": 187,
    "188": 188,
    "Duration of volatile sedation, hr": 188,
    "189": 189,
    "DVT prophylaxis": 189,
    "190": 190,
    "Dyspnea": 190,
    "Dyspnoea": 190,
    "191": 191,
    "EBV PCR": 191,
    "192": 192,
    "ECG": 192,
    "ECG (rhythm)": 192,
    "ECG (ST-segment changes)": 192,
    "193": 193,
    "ECMO": 193,
    "194": 194,
    "EEG findings": 194,
    "195": 195,
    "EGFR (ml/min/1.73\u2009m2)": "GFR (ml/min)",
    "eGFR (normal \u226560 mL/min/1.73 m2)": 195,
    "eGFR,c mL/min/1.73 m2": 195,
    "196": 196,
    "Eosinophil": 196,
    "Eosinophil percentage (0.5\u20135%)": 196,
    "Eosinophils": 196,
    "Eosinophils (0.0\u20130.4 \u00d7 109/L)": 196,
    "197": 197,
    "Epidemiology": "COVID-19 disease severity",
    "198": 198,
    "Erythrocyte sedimentation rate (ESR)": 198,
    "Erythrocyte Sedimentation Rate (ESR) (<20 mm/h)": 198,
    "Erythrocyte sedimentation rate (mm/hr)": 198,
    "ERS (0-20\u2009mm /h)": 198,
    "ESR (0\u201320\u00a0\u200bmm/h)": 198,
    "ESR (mm/hr)": 198,
    "ESR (normal 0\u201315 mm/h)": 198,
    "ESR mm 5\u201312": 198,
    "ESR\u00a0(mm/h)": 198,
    "Erythrocytes,\u00a0\u00d7106/\u03bcL": 198,
    "199": 199,
    "Esketamine, mg kg\u20131 hr\u20131": 199,
    "200": 200,
    "Estimated length of stay (days)": "Hospital LOS",
    "201": 201,
    "Etiological exploration": 201,
    "202": 202,
    "Etiology of cirrhosis": "Prothrombin time",
    "203": 203,
    "Evidence of right heart strain": "Cardiovascular risk factors",
    "204": 204,
    "Exposure history": 204,
    "205": 205,
    "Fatigue": "Fatigue",
    "206": 206,
    "Favipravir*": "COVID-19 medication",
    "207": 207,
    "FBS mg/dl 70\u2013115": 207,
    "208": 208,
    "Ferritin": 208,
    "Ferritin (\u00b5g/L)": 208,
    "Ferritin (10.0\u2013300\u00a0\u200bng/ml)": 208,
    "Ferritin (10\u2013350 ug/L)": 208,
    "Ferritin (15\u2013150\u00a0ng/L)": 208,
    "Ferritin (4.6\u2013204 U/L)": 208,
    "Ferritin (8-252\u2009ng/mL)": 208,
    "Ferritin (8\u2013388 ng/mL)": 208,
    "Ferritin (ng/mL)": 208,
    "Ferritin (ng/ml)": 208,
    "Ferritin (normal 30\u2013400 ng/mL)": 208,
    "Ferritin (reference range 30-400 ng/mL)": 208,
    "Ferritin (ug/L)": 208,
    "Ferritin levels (ng/ml)": 208,
    "Ferritin microg/l": 208,
    "Ferritin ng/ml": 208,
    "Ferritin ng/mL": 208,
    "Ferritin, ng/mL": 208,
    "209": 209,
    "FEV1 l (%), n (%)": 209,
    "210": 210,
    "Fibrinogen": 210,
    "Fibrinogen (2.0 to 4.0 g/L)": 210,
    "Fibrinogen (200\u2013385 mg/dL)": 210,
    "Fibrinogen (200\u2013393\u00a0\u200bmg/dL)": 210,
    "Fibrinogen (g/L)": 210,
    "Fibrinogen (g/L) RR 2\u20134": 210,
    "Fibrinogen (mg/dL)": 210,
    "Fibrinogen (mg/dL) (180-400)": 210,
    "Fibrinogen g/l": 210,
    "Fibrinogen, mg/dL": 210,
    "211": 211,
    "First symptoms of COVID-19": 211,
    "First episode symptoms(D0)": 211,
    "212": 212,
    "Fisher grade for SAH": 212,
    "213": 213,
    "Folate": 213,
    "214": 214,
    "Follow up after hydroxychloroquine and heparin": 214,
    "215": 215,
    "Fungal pneumonia": 215,
    "216": 216,
    "GA at fetal death, weeks": 216,
    "217": 217,
    "Gamma glutamyl transferase (GGT)": 217,
    "Gamma-glutamyl transferase, U/L": 217,
    "218": 218,
    "Gestational age at illness onset (weeks)": "\u0443\u0431\u0440\u0430\u0442\u044c",
    "219": 219,
    "GFR (ml/min)": "GFR (ml/min)",
    "220": 220,
    "GGT (IU/L)": 220,
    "GGT (U/L)": 220,
    "221": 221,
    "Globulin (g/L, 20~35)": 221,
    "222": 222,
    "GLU (3.9\u20136.1\u2009mmol/L)": "Glucose mg/dl",
    "223": 223,
    "Glucocorticoids": 223,
    "224": 224,
    "Glucose mg/dl": "Glucose mg/dl",
    "Glucose, mg/dL": 224,
    "225": 225,
    "Glutamyl transpeptidase (8- 58\u2009U/L)": 225,
    "226": 226,
    "Glycated hemoglobin (%)": "Hemoglobin",
    "227": 227,
    "Gravida (G), Para (P)": " \u0443\u0431\u0440\u0430\u0442\u044c",
    "228": 228,
    "Haemorrhagic transformation": 228,
    "229": 229,
    "Haptoglobin": 229,
    "Haptoglobin (g/L)": 229,
    "230": 230,
    "HBV serology": 230,
    "231": 231,
    "HCO3 (mmol/L)": 231,
    "HCO3\u2212 (mmol/L)": 231,
    "232": 232,
    "Hct % Female: 36\u201344.5Male: 41.5\u201350.4": 232,
    "233": 233,
    "HCV serology": 233,
    "234": 234,
    "Headache": 234,
    "235": 235,
    "Hematocrit (%)": 235,
    "Hematocrit, % [range: 40\u201354]": 235,
    "Hematocrit": 235,
    "236": 236,
    "Hematological disease": 236,
    "237": 237,
    "Hemoglobin": 237,
    "Hemoglobin (115\u2013160 g/L)": 237,
    "Hemoglobin (12\u201316\u00a0g/dL)": 237,
    "Hemoglobin (13\u201317\u00a0\u200bg/dL)": 237,
    "Hemoglobin (g/dL)": 237,
    "Hemoglobin (g/dl)": 237,
    "Hemoglobin (g/L)": 237,
    "Hemoglobin A1C (4\u20136%)": 237,
    "Hemoglobin, g/dL": 237,
    "Hemoglobin, g/dl": 237,
    "Hemoglobin, g/dl [range: 14\u201318]": 237,
    "Haemoglobin (g/L)": 237,
    "Haemoglobin (131-172\u2009g/L)": 237,
    "Haemoglobin (115 \u2013 155 g/L)": 237,
    "Haemoglobin g/dl": 237,
    "Hb g/dl Female: 12.3\u201315.3Male: 14\u201317": 237,
    "238": 238,
    "High flow oxygen": "Oxygen saturation",
    "239": 239,
    "High-density lipoprotein (HDL) (>1 mmol/L)": 239,
    "240": 240,
    "Highest temperature, \u00b0C": 240,
    "Fever": 240,
    "241": 241,
    "High-sensitivity cardiac troponin I (pg/mL)": "Troponin I",
    "High-sensitivity cardiac troponin I (pg/ml)": 241,
    "242": 242,
    "Histological type": 242,
    "243": 243,
    "Histopathology Lymphocytic infiltration": 243,
    "244": 244,
    "Histopathology MVP": 244,
    "245": 245,
    "Histopathology Necrosis": 245,
    "246": 246,
    "Histopathology Percentage of small cell component (%)": 246,
    "247": 247,
    "Historical HR (b.p.m.)": 247,
    "248": 248,
    "History of MG (y)": 248,
    "249": 249,
    "History of thrombosis": 249,
    "250": 250,
    "HIV serology": 250,
    "251": 251,
    "Home Immunosuppression": "Immunosuppressant",
    "252": 252,
    "Hospital admission": 252,
    "253": 253,
    "Hospital Course": "Hospital LOS",
    "254": 254,
    "Hospital day conduction disease developed": 254,
    "255": 255,
    "Hospital day of CCP": 255,
    "256": 256,
    "Hospital LOS (d)": 256,
    "Hospitalization days": 256,
    "Length of Stay (d)": 256,
    "Length of stay (days)": 256,
    "Length of stay in days": 256,
    "Length of stay, days": 256,
    "Length of hospital stay, days": 256,
    "257": 257,
    "Hospital treatment time (for COVID) (days)": 257,
    "258": 258,
    "Hospitalization after SARS-CoV-2 diagnosis (days)": 258,
    "259": 259,
    "hsTpnT (normal \u226422 ng/L)": 259,
    "260": 260,
    "Hydrocephalus": 260,
    "261": 261,
    "Hydroxychloroquine dependent RBC antibody": 261,
    "262": 262,
    "Hypertension": 262,
    "263": 263,
    "ICU admission": 263,
    "ICU admission and disease severity": 263,
    "Intensive care": 263,
    "264": 264,
    "ICU LOS (d)": 264,
    "Intensive care unit stay (days)": 264,
    "265": 265,
    "IgG anti-S1-S2\u00a0AU/ml": 265,
    "266": 266,
    "IL-1 Beta (<3.9 pg/mL)": 266,
    "Interleukin-1\u03b2 (pg/ml, <\u20095.0)": 266,
    "267": 267,
    "IL-10 (<2.00 pg/mL)": 267,
    "268": 268,
    "IL-6": 268,
    "IL-6 (<5.00 pg/mL)": 268,
    "IL-6 (0.0\u20136.3\u00a0\u200bpg/ml)": 268,
    "IL-6 (0\u20136.3\u00a0pg/mL)": 268,
    "IL-6 (normal \u22645.0 pg/mL)": 268,
    "IL-6 (pg/ml)": 268,
    "IL-6 levels": 268,
    "IL6 pg/ml": 268,
    "IL-6, pg/mL": 268,
    "Interleukin-6 (IL-6)": 268,
    "Interleukin-6 (pg/ml, <\u20097.0)": 268,
    "Interleukin 6 pg/ml": 268,
    "269": 269,
    "Imaging features": 269,
    "Imaging features at ICU admission": 269,
    "Imaging result": 269,
    "270": 270,
    "Immuno-histo-chemistry 1p/19q codeletion": 270,
    "271": 271,
    "Immuno-histo-chemistry ATRX": 271,
    "272": 272,
    "Immuno-histo-chemistry Cytokeratin, TTF1 CD45, CD3, CD20, Neurofilament protein and Neu N": 272,
    "273": 273,
    "Immuno-histo-chemistry EGFR amplification": "GFR (ml/min)",
    "274": 274,
    "Immuno-histo-chemistry IDH1R132H mutation": 274,
    "275": 275,
    "Immuno-histo-chemistry Ki-67": 275,
    "276": 276,
    "Immuno-histo-chemistry p53 mutation": 276,
    "277": 277,
    "Immunoregulator": 277,
    "278": 278,
    "Immunosuppressant": 278,
    "279": 279,
    "Improvement/deterioration after surgery": 279,
    "280": 280,
    "Indirect bilirubin (2-17umol/ L)": 280,
    "281": 281,
    "Induction treatment": 281,
    "282": 282,
    "Infection-related biomarkers": 282,
    "283": 283,
    "International normalised ratio (INR)": 283,
    "INR": 283,
    "International Normalised Ratio (INR) (0.9 \u2013 1.2 ratio)": 283,
    "International normalized ratio": 283,
    "International normalized ratio (INR)": 283,
    "International Normalized Ratio (INR) (0.85\u20131,15 ratio)": 283,
    "INRI (0.9\u20131.1)": 283,
    "284": 284,
    "Interval between onset and admission (days)": 284,
    "Interval until Resolution, days": 284,
    "285": 285,
    "Intervals (ms)": 285,
    "286": 286,
    "Intravenous immunoglobulin": 286,
    "287": 287,
    "Ionized calcium, mEq/L": 287,
    "288": 288,
    "Iron": 288,
    "Iron saturation": 288,
    "289": 289,
    "IV sedation prior to isoflurane, mean \u00b1 sd": 289,
    "290": 290,
    "Jaundice/icterus": 290,
    "291": 291,
    "K": 291,
    "292": 292,
    "K Time (0.5-2.3\u2009min)": 292,
    "293": 293,
    "K(ser) mEq/L 3.6\u20135.9": 293,
    "K, mEq/L [range: 3.5\u20135.1]": 293,
    "294": 294,
    "K+ (normal 3.5\u20135.1 mmol/L)": 294,
    "295": 295,
    "Karnofsky performance status (KPS)": 295,
    "296": 296,
    "Kidney pathology": 296,
    "297": 297,
    "Laboratory findings": 297,
    "Laboratory values": 297,
    "Laboratory Findingsa": 297,
    "Laboratory findings on the day of first or only ischaemic stroke event": 297,
    "Laboratory findings at the time ICH diagnosed": 297,
    "Laboratory investigations during second admission": 297,
    "Laboratory characteristics": 297,
    "Laboratories at admission": 297,
    "298": 298,
    "Lactate": 298,
    "Lactate (mmol/L)": 298,
    "Lactate (normal 0.5\u20131.6 mmol/L)": 298,
    "Lactate, mg/dL": 298,
    "LactateReference: 0.5\u20132.2 mmol/l": 298,
    "299": 299,
    "Lactate dehydrogenase": 299,
    "Lactate dehydrogenase (100\u2013248 IU/L)": 299,
    "Lactate dehydrogenase (115 -220\u2009U/L)": 299,
    "Lactate dehydrogenase (50\u2013242\u00a0U/L)": 299,
    "Lactate dehydrogenase (81-234\u2009units/L)": 299,
    "Lactate dehydrogenase (LDH)": 299,
    "Lactate dehydrogenase (U/L)": 299,
    "Lactate dehydrogenase (U/L, 135~225)": 299,
    "Lactate dehydrogenase, IU/L": 299,
    "Lactate dehydrogenase, U/L": 299,
    "LDH (87\u2013247 U/L)": 299,
    "LDH (IU/L)": 299,
    "LDH (reference range 135-225 U/L)": 299,
    "LDH (U/L)": 299,
    "LDH (UI/L)": 299,
    "LDH levels (U/L)": 299,
    "LDH U/L": 299,
    "LDH U/l": 299,
    "LD": 299,
    "300": 300,
    "Large vessel occlusion": 300,
    "301": 301,
    "Length of Readmission (days)": "Hospital LOS",
    "302": 302,
    "Leukocyte count": 302,
    "Leucocytes \u00d7\u200910^9/L": 302,
    "Leukocytes count (G/L)": 302,
    "Leukocytes, 103/ml [range: 5.0\u201310.0]": 302,
    "Leukocytes,\u00a0\u00d7103/\u03bcL": 302,
    "303": 303,
    "Levels of CK and other inflammatory markers at time of diagnosis of SARS-CoV-2 infection": 303,
    "304": 304,
    "Lipase": 304,
    "Lipase, U/L": 304,
    "305": 305,
    "Liver function tests": 305,
    "306": 306,
    "Location of clot": 306,
    "307": 307,
    "Location of hematoma": 307,
    "308": 308,
    "Location of ICH": 308,
    "309": 309,
    "Lormetazepam, mg kg\u20131 min\u20131": 309,
    "310": 310,
    "Low-density lipoprotein (LDL) (<3.4 mmol/L)": 310,
    "311": 311,
    "Lung involvement": "CT",
    "312": 312,
    "Lupus anticoagulant": "COVID-19 medication",
    "313": 313,
    "LV": 313,
    "314": 314,
    "Lymphocytes": 314,
    "Lymphocyte (\u00d7\u2009109/L)": 314,
    "lymphocyte (1.5\u20134.3) 10^9/L": 314,
    "Lymphocyte count": 314,
    "Lymphocyte count (0.8\u20134\u00d7 109/L)": 314,
    "Lymphocyte count (109/L)": 314,
    "Lymphocyte count (K/mm3)": 314,
    "Lymphocyte count,\u00a0\u00d7 103/\u03bcL": 314,
    "Lymphocyte\u00a0(*109/l)": 314,
    "Lymphocytes (%)": 314,
    "Lymphocytes (*109/L, 1.1~3.2)": 314,
    "Lymphocytes (/mmc)": 314,
    "Lymphocytes (1.2\u20133.4\u00a0\u200bK/\u03bcL)": 314,
    "Lymphocytes (1.2\u20133.4\u00a0K/\u03bcL)": 314,
    "Lymphocytes (1.3 \u2013 4.0 x 109/L)": 314,
    "Lymphocytes (1.5\u20134.0 \u00d7 109/L)": 314,
    "Lymphocytes \u00d7\u200910^9/L": 314,
    "Lymphocytes 10^9/l": 314,
    "Lymphocytes percent (%, 20.0~50.0)": 314,
    "Lymphocytes, %": 314,
    "Lymphocytes, % [range: 16\u201345]": 314,
    "315": 315,
    "Lymphopenia (<0.4 \u00d7 109/l)": 315,
    "316": 316,
    "Management": "Treatment",
    "317": 317,
    "Manifestation of thrombotic event": "History of thrombosis",
    "318": 318,
    "MAP (mmHg), mean (range)": 318,
    "319": 319,
    "Max amplitude (52-57\u2009mm)": 319,
    "320": 320,
    "Max Resp Support": "Oxygen saturation",
    "Maximum O2 support": 320,
    "321": 321,
    "Maximum Richmond-Agitation-Sedation Scale deviation from required sedation deptha": 321,
    "322": 322,
    "MCH (pg)": 322,
    "MCH pg 27.5\u201333.2": 322,
    "323": 323,
    "MCHC (g/dl)": 323,
    "MCHC g/dL 30.0\u201338.0": 323,
    "324": 324,
    "MCV (fl)": 324,
    "MCV fl 80\u201396": 324,
    "MCV (fL)": 324,
    "325": 325,
    "Mean corpuscular hemoglobin concentration": 325,
    "326": 326,
    "Mean corpuscular volume": 326,
    "Mean corpuscular volume (MCV)": 326,
    "327": 327,
    "Mechanical Ventilator Status": 327,
    "Mechanical ventilation required": 327,
    "Mechanical ventilation (days)": 327,
    "Intubated": 327,
    "Invasive mechanical ventilation": 327,
    "Invasive ventilator": 327,
    "328": 328,
    "Medications": "COVID-19 medication",
    "Medication on admission": 328,
    "Medications Received": 328,
    "329": 329,
    "Melaena": 329,
    "330": 330,
    "MELD score": 330,
    "331": 331,
    "Mg (normal 1.6\u20132.4 mg/dL)": 331,
    "332": 332,
    "MGCS at admission": 332,
    "333": 333,
    "MGCS at discharge": 333,
    "334": 334,
    "MGFA before COVID-19": 334,
    "MGFA classification at admission": 334,
    "335": 335,
    "MGFA classification at discharge": 335,
    "336": 336,
    "Midazolam, mg kg\u20131 hr\u20131": 336,
    "337": 337,
    "Mode of ventilation": "Mechanical Ventilator Status",
    "338": 338,
    "Modified Rankin Scale (mRS, 0\u20136) (discharge)": 338,
    "339": 339,
    "Modified Rankine Score at time of writing (0\u20136)": 339,
    "340": 340,
    "Modified TOAST": 340,
    "341": 341,
    "Monocytes": 341,
    "Monocytes (0.2\u20130.8 \u00d7 109/L)": 341,
    "Monocyte\u00a0(*109/l)": 341,
    "Monocytes (0.2\u20131.0 x 109/L)": 341,
    "342": 342,
    "MRI Findings": 342,
    "MRI findings": 342,
    "MRI (after radiotherapy)": 342,
    "MRI (pre-operation) Focality": 342,
    "MRI (pre-operation) Perilesional edema and mass effect": 342,
    "MRI (pre-operation) Postcontrast enhancement": 342,
    "MRI (pre-operation) Site": 342,
    "MRI (pre-operation) Size (cm)": 342,
    "MRI spine": 342,
    "343": 343,
    "Myalgia": 343,
    "Myalgia or arthralgia": 343,
    "344": 344,
    "Myoglobin (ng/mL, \u2264\u2009154.9)": 344,
    "Myoglobin (<21\u2009ng/ml)": 344,
    "345": 345,
    "N terminal probrain natriuretic peptide (ng/L)": 345,
    "346": 346,
    "Na": 346,
    "347": 347,
    "Na(ser) mEq/L 138\u2013145": 347,
    "348": 348,
    "Na, 134-144 mmol/L": 348,
    "349": 349,
    "Na, mEq/L [range: 135\u2013145]": "Na",
    "350": 350,
    "Nadir HR (b.p.m.)": 350,
    "351": 351,
    "Nasal catheter": 351,
    "352": 352,
    "Nasal congestion": 352,
    "353": 353,
    "Nasopharyngeal swab": 353,
    "354": 354,
    "Nausea": 354,
    "Nausea/vomiting": 354,
    "Vomit": 354,
    "355": 355,
    "NCS findings": 355,
    "356": 356,
    "Negative by PERC Criteria": 356,
    "357": 357,
    "Neurological history": "Clinical characteristics",
    "358": 358,
    "Neurological problem from COVID-19": 358,
    "359": 359,
    "Neutrophil": 359,
    "Neutrophil (\u00d7109 L)": 359,
    "Neutrophil count (109/L)": 359,
    "Neutrophil count,\u00a0\u00d7 103/\u03bcL": 359,
    "Neutrophil percentage (45\u201377%)": 359,
    "Neutrophil\u00a0(*109/l)": 359,
    "Neutrophils": 359,
    "Neutrophils % [range: 45\u201374]": 359,
    "Neutrophils (*109/L, 1.8~6.3)": 359,
    "Neutrophils (/mmc)": 359,
    "Neutrophils (\u00d7\u2009109/L)": 359,
    "Neutrophils (1.4\u20136 K/\u03bcL)": 359,
    "Neutrophils (1.4\u20136.5\u00a0K/\u03bcL)": 359,
    "Neutrophils (1.8\u20137.5 \u00d7 109/L)": 359,
    "Neutrophils (2.2 \u2013 6.3 x 109/L)": 359,
    "Neutrophils \u00d7\u200910^9/L": 359,
    "Neutrophils percent (%, 40.0~75.0)": 359,
    "Neutrophils(30.0\u201370.0) 10^9/L": 359,
    "Neutrophyl/Lymphocyte (K/uL)": 359,
    "360": 360,
    "New Antibodies in Serum": 360,
    "361": 361,
    "NIHSS": 361,
    "NIHSS 24\u00a0\u200bh": 361,
    "NIHSS after 24\u00a0h": 361,
    "NIHSS at baseline": 361,
    "NIHSS discharge": 361,
    "NIHSS initial": 361,
    "NIHSS*": 361,
    "362": 362,
    "NLR": 362,
    "363": 363,
    "No Toxic Granules Seen": 363,
    "364": 364,
    "Noninvasive ventilation": "Mechanical Ventilator Status",
    "Non-invasive ventilation (days)": 364,
    "Non-invasive ventilator": 364,
    "365": 365,
    "NP swabs after 18F FDG PET/CT": 365,
    "366": 366,
    "N-terminal pro-B-type natriuretic peptide (pg/mL, <\u2009241)": 366,
    "367": 367,
    "NT-pro-B-type natriuretic peptide (NT-pro-BNP) (pg/mL)": 367,
    "368": 368,
    "Nucleic acid recovery positive": 368,
    "369": 369,
    "Nutrition support": 369,
    "370": 370,
    "OI (400-500\u2009mmHg)": 370,
    "371": 371,
    "Onset of PRES from hospitalization": 371,
    "372": 372,
    "Organ involvement prior to ICH": 372,
    "373": 373,
    "Other vascular imaging": 373,
    "374": 374,
    "Others": 374,
    "375": 375,
    "Outpatient baseline kidney function creatinine (reference range 0.7-1.5 mg/dL); eGFR (reference range >60)": "GFR (ml/min)",
    "376": 376,
    "Outpatient medications included": "Medications",
    "377": 377,
    "Oxygen requirement": "Oxygen therapy",
    "378": 378,
    "Oxygen saturation (%) during admission, mean (range)": "Oxygen saturation",
    "Oxygen saturation (%, 95~99)": 378,
    "O2 saturation (RA) on second admission": 378,
    "379": 379,
    "Oxygen therapy": 379,
    "Oxygen therapy required": 379,
    "380": 380,
    "P": 380,
    "p mg/dl 2.7\u20134.5": 380,
    "381": 381,
    "PaCO2 (Torr)": 381,
    "PaO2 (Torr)": 381,
    "382": 382,
    "Palpitations": 382,
    "383": 383,
    "Parameter": 383,
    "384": 384,
    "Parity": 384,
    "385": 385,
    "Partial pressure of carbon dioxide (kPA) [mmHg] on 15 litres of oxygen": "Oxygen therapy",
    "386": 386,
    "Partial pressure of oxygen (kPA) [mmHg] on 15 litres of oxygen": "Oxygen saturation",
    "Partial pressure of oxygen (mmHg, 80~100)": 386,
    "387": 387,
    "Partial thromboplastin time": "Prothrombin time",
    "388": 388,
    "PCO2 (35-45\u2009mmHg)": 388,
    "pCO2 (mm Hg)": 388,
    "Pco2, mm Hg": 388,
    "389": 389,
    "PCT (ng/mL)": "Procalcitonin (ng/mL)",
    "PCT ng/ml": 389,
    "390": 390,
    "Peak SCr (mg/dl)": "Serum creatinine",
    "391": 391,
    "Peak value for CK and other inflammatory markers": 391,
    "392": 392,
    "Period from initial symptoms to diagnosis of pneumonia (days)": 392,
    "393": 393,
    "Peripheral blood smear": 393,
    "394": 394,
    "Pertinent medical history": 394,
    "395": 395,
    "Pertinent neurological findings": 395,
    "396": 396,
    "pH": 396,
    "PH (7.35\u20137.45)": 396,
    "Plasma haemoglobin (g/L)": 396,
    "397": 397,
    "Placental and fetal histopathology": 397,
    "398": 398,
    "Platelet": 398,
    "Platelet (/mL)": 398,
    "Platelet (\u00d7\u2009109/L)": 398,
    "Platelet count": 398,
    "Platelet count (/\u00b5L)": 398,
    "Platelet count (/mm3)": 398,
    "Platelet count (\u00d7 109/L)": 398,
    "Platelet count (100\u2013300\u00d7 109/ L)": 398,
    "Platelet count (109/L)": 398,
    "Platelet count (130\u2013400 per mm3)": 398,
    "Platelet count (150 \u2013 450 x 109/L)": 398,
    "Platelet count (150\u2013450 \u00d7 109/L)": 398,
    "Platelet count (K/uL)": 398,
    "Platelet count (per mm3)": 398,
    "Platelet count (x103/\u03bcL)": 398,
    "Platelet count, \u00d7 109/l": 398,
    "Platelet count, k/\u03bcL": 398,
    "Platelet count,\u00a0\u00d7 103/\u03bcL": 398,
    "Platelets": 398,
    "Platelets (*109/l)": 398,
    "Platelets (\u00d7109L)": 398,
    "Platelets \u00d7\u200910^9/L": 398,
    "Platelets, 103/ml [range: 150\u2013450]": 398,
    "Plt \u00d7\u20091000/\u03bcL 140\u2013440": 398,
    "399": 399,
    "Pleural effusion": 399,
    "400": 400,
    "Pneumonic infiltration compatible with COVID (%)": 400,
    "401": 401,
    "PO2 (80-100\u2009mmHg)": 401,
    "Po2, mm Hgb": 401,
    "402": 402,
    "Poor appetite": 402,
    "403": 403,
    "PORT": 403,
    "404": 404,
    "Positive serology": 404,
    "405": 405,
    "Possible mechanism of neuronal injury": 405,
    "406": 406,
    "Postoperative hospital stay (days)": 406,
    "407": 407,
    "Postoperative morbidity": "Death",
    "408": 408,
    "Potassium (mEq/L)": 408,
    "Potassium (mmol/l)": 408,
    "Potassium, mEq/L": 408,
    "Potassium (mmol/L)": 408,
    "409": 409,
    "PR (ms)": 409,
    "410": 410,
    "Pressors": 410,
    "411": 411,
    "Pre-stroke mRS (0-5)": 411,
    "412": 412,
    "Previous cancer": "Comorbidity",
    "413": 413,
    "Prior to isoflurane (data collected in the last 30\u2009min before initiation of volatile sedation)": "Clinical characteristics",
    "414": 414,
    "Prior to prednisolone 40\u00a0mg bid": 414,
    "415": 415,
    "Pro-b-type natriuretic peptide (pg/mL)": 415,
    "416": 416,
    "Procalcitonin (ng/mL)": 416,
    "Procalcitonin (\u22640.5(ng/ml)": 416,
    "Procalcitonin (0.00\u20130.10\u00a0\u200bng/ml)": 416,
    "Procalcitonin (0.02\u20130.10\u00a0ng/mL)": 416,
    "Procalcitonin (ng/mL, 0.02~0.05)": 416,
    "Procalcitonin (reference range 0-0.08 ng/mL)": 416,
    "Procalcitonin ng/mL": 416,
    "Procalcitonin, <0.10 ng/mL/lactate, 0.4-2.0 mmol/L": 416,
    "417": 417,
    "Prone positioning, hr": 417,
    "418": 418,
    "Prophylactic antimicrobials": 418,
    "419": 419,
    "ProphylacticAnticoagulation": 419,
    "420": 420,
    "Propofol, mg kg\u20131 hr\u20131": 420,
    "421": 421,
    "Protein immunoelectrophoresis": 421,
    "422": 422,
    "Prothrombin time": 422,
    "Prothrombin Time (9.95\u201312.87\u00a0s)": 422,
    "Prothrombin time (s)": 422,
    "Prothrombin time (s) RR 10\u201313\u2009s": 422,
    "Prothrombin time (s, 11.5~14.5)": 422,
    "Prothrombine time (sec)": 422,
    "PT (10.6\u201313.7 sec)": 422,
    "PT (9.8-12.0) sec": 422,
    "PT (s)": 422,
    "PT (sec)": 422,
    "PT sec": 422,
    "PT, 9.4- 15.4 s/INR, 0.8 - 1.3 ratio": 422,
    "PT, s": 422,
    "PT": 422,
    "423": 423,
    "PT (%)": "Prothrombin time",
    "424": 424,
    "PT/ATT": "Prothrombin time",
    "425": 425,
    "PT-INR (0,8-1,2)": 425,
    "426": 426,
    "pTNM": 426,
    "427": 427,
    "PTT (sec)": "Prothrombin time",
    "428": 428,
    "Pulmonary Hypertension": 428,
    "429": 429,
    "QRS (ms)": 429,
    "430": 430,
    "QT-prolonging drugs": 430,
    "431": 431,
    "Race": 431,
    "Ethnicity": 431,
    "Nationality": 431,
    "432": 432,
    "Rate (beats/min)": "Rhythm",
    "433": 433,
    "RBC Count": 433,
    "RBC \u00d7\u20091,000,000/\u03bcL Female: 4.5\u20135.1Male: 4.5\u20136.5": 433,
    "RBC\u00a0(*106 cells/mcl)": 433,
    "434": 434,
    "Readmission imaging": 434,
    "435": 435,
    "Readmission O2 requirement (L)": 435,
    "436": 436,
    "Readmisson SaO 2 (%)": "Oxygen saturation",
    "437": 437,
    "Receptor-binding domain endpoint titer": 437,
    "438": 438,
    "Recovery": "Death",
    "439": 439,
    "Recovery CK and other inflammatory markers prior to discharge": 439,
    "440": 440,
    "Red blood cell (x106/\u03bcL)": "RBC Count",
    "Red blood cells count (4.5\u20135.7 \u00d7 1012/L)": 440,
    "441": 441,
    "Red blood cell distribution width": 441,
    "442": 442,
    "Reference": 442,
    "443": 443,
    "Renal replacement therapy": 443,
    "444": 444,
    "Required ICU care": "ICU admission",
    "445": 445,
    "Resolution of CXR abnormality at discharge": "Chest X ray finding",
    "446": 446,
    "Respiratory": "Oxygen saturation",
    "447": 447,
    "Respiratory involvement": "Oxygen saturation",
    "448": 448,
    "Respiratory support": 448,
    "449": 449,
    "Reticulocyte percent": 449,
    "450": 450,
    "Reumatoid factor": 450,
    "Rheumatoid factor search": 450,
    "451": 451,
    "Rhythm": 451,
    "452": 452,
    "Rhythms developed": 452,
    "453": 453,
    "Risc factors": 453,
    "Risk Factor for PTX": 453,
    "Risk factors": 453,
    "Risk factors for PRES": 453,
    "Risk factors for pulmonary embolism": 453,
    "Risk factors for stroke": 453,
    "454": 454,
    "RT-PCR in placenta and AF": 454,
    "455": 455,
    "RV": 455,
    "456": 456,
    "Sample type": 456,
    "457": 457,
    "SARS-COV-2 IgG (Abbot)": 457,
    "458": 458,
    "SARS-CoV-2 PCR (date &CTV)": 458,
    "459": 459,
    "SARS-Cov2 Total Antibody Screening": "IgG anti-S1-S2\u00a0AU/ml",
    "460": 460,
    "Schizocytes search": 460,
    "461": 461,
    "Second episode symptoms": 461,
    "462": 462,
    "Seizure semiology": 462,
    "463": 463,
    "Serologic studies including ANA,DSDNA, P-ANCA, C-ANCA, APL complements": 463,
    "464": 464,
    "Serum albumin": 464,
    "465": 465,
    "Serum creatinine": "Creatinine mg/dl",
    "Serum calcium (mg/dl)": 465,
    "Serum creatinine (mg/dl)": 465,
    "Serum creatinine (\u03bcmol/L)": 465,
    "Serum creatinine level at outcome (mg/dl)": 465,
    "Serum creatinine on presentation (mg/dl)": 465,
    "Serum creatinine values during hospital stay (mg/dl)": 465,
    "Serum creatinine, mg/dL": 465,
    "Serum creatinine, mg/dl": 465,
    "466": 466,
    "Serum ferritin (\u03bcg/L)": 466,
    "467": 467,
    "Serum inflammatory markers": 467,
    "468": 468,
    "Serum magnesium (mg/dl)": 468,
    "469": 469,
    "Serum Na (136\u2013145 mmol/l)": 469,
    "470": 470,
    "Serum phosphate (mg/dl)": 470,
    "471": 471,
    "Severity of pneumothorax": 471,
    "472": 472,
    "Severity on diagnosis of pneumonia": 472,
    "473": 473,
    "Sex": 473,
    "Sex (M/F)": 473,
    "Sex, F/M": 473,
    "Gender": 473,
    "474": 474,
    "SF ratio": 474,
    "475": 475,
    "SGOT(AST) IU/L Female up to 31Male: <\u200940": 475,
    "476": 476,
    "SGPT (U/L)": 476,
    "477": 477,
    "SGPT(ALT) IU/L Female: <\u200931Male: <\u200945": 477,
    "478": 478,
    "Shock": 478,
    "479": 479,
    "Shortness of breath": 479,
    "480": 480,
    "Signs and symptoms of pulmonary embolism": 480,
    "481": 481,
    "Simplified Acute Physiology Score II at time of admission, points": 481,
    "482": 482,
    "Since hospital admission": 482,
    "483": 483,
    "Since intubation": "Mechanical Ventilator Status",
    "484": 484,
    "Size of PTX": 484,
    "485": 485,
    "Skin pathology": 485,
    "486": 486,
    "Smoking": 486,
    "Smoking history": 486,
    "Smoking histrory": 486,
    "Smoking status": 486,
    "487": 487,
    "Sodium (mEq/L)": 487,
    "Sodium, mEq/L": 487,
    "Sodium (mmol/L)": 487,
    "Sodium (mmol/l)": 487,
    "488": 488,
    "SOFA": 488,
    "SOFA-score at diagnosis of arterial thromboembolism": 488,
    "489": 489,
    "Sore throat": 489,
    "490": 490,
    "Source of infection": 490,
    "491": 491,
    "SpO2 (%)": 491,
    "492": 492,
    "Sputum": 492,
    "Sputum production": 492,
    "493": 493,
    "ST/T-wave changes": 493,
    "494": 494,
    "Stem cell Transplant type": 494,
    "495": 495,
    "Stomach ache": 495,
    "496": 496,
    "Stroke features": 496,
    "497": 497,
    "Stroke risk factors": "Cardiovascular risk factors",
    "498": 498,
    "Stroke symptom and signs": 498,
    "499": 499,
    "Stroke type": 499,
    "500": 500,
    "Subcutaneous emphysema orpneumomediastinum": 500,
    "501": 501,
    "Sufentanil, \u00b5g kg\u20131 hr\u20131, mean \u00b1 sd": 501,
    "502": 502,
    "Superimposed pneumonia": 502,
    "503": 503,
    "Supplemental O2 at discharge (liters)": "Oxygen therapy",
    "504": 504,
    "Surgical procedure": 504,
    "505": 505,
    "Suspicious clinical features": 505,
    "506": 506,
    "Symptom duration, d": "Duration of symptoms",
    "Symptomatic Days PTA": 506,
    "507": 507,
    "Symptoms attributable to PRES": 507,
    "508": 508,
    "The time between the onset of COVID-19 infection and onset of ICH (days)": 508,
    "509": 509,
    "Therapy": 509,
    "510": 510,
    "Thoracic imaging": 510,
    "511": 511,
    "Thorax CT Findings": "CT",
    "512": 512,
    "Thrombocyte count": 512,
    "Thrombocytes,\u00a0\u00d7103/\u03bcL": 512,
    "Thrombocytes(150\u2013450\u00a0\u00d7\u00a0109/L)": 512,
    "513": 513,
    "Thromboembolic event": 513,
    "514": 514,
    "Thrombosis clinic after how many days after discharge (days)": 514,
    "515": 515,
    "Time between symptom onset and ICH identification (days)": 515,
    "516": 516,
    "Time from HCT to COVID-19 symptoms": 516,
    "517": 517,
    "Time from illness onset to first hospital admission (days)": 517,
    "518": 518,
    "Time from initial COVID-19 diagnosis": 518,
    "519": 519,
    "Time to onset, days": 519,
    "520": 520,
    "Time to volatile sedation, d": 520,
    "521": 521,
    "TNF-\u03b1 (pg/ml, <\u20098.1)": 521,
    "522": 522,
    "Tocilizumab (400 mg per dose)": "COVID-19 medication",
    "523": 523,
    "Total bilirubin": 523,
    "Total Bilirubin": 523,
    "Total bilirubin (\u00b5mol/L)": 523,
    "Total bilirubin (5.1\u201320 umol /L)": 523,
    "Total bilirubin (\u03bcmol/L)": 523,
    "Total bilirubin, mg/dL": 523,
    "524": 524,
    "Total bilirubin/direct bilirubin, 0.3-1.2/0.1-0.4 mg/dL": "Total bilirubin",
    "525": 525,
    "Total cholesterol (<5.2 mmol/L)": 525,
    "526": 526,
    "Total creatine kinase (U/L)": "Creatine kinase",
    "527": 527,
    "Total iron-binding capacity": 527,
    "528": 528,
    "Total leucocyte count (x103/\u03bcL)": 528,
    "529": 529,
    "Total protein/albumin, 6.1-8.1/ 3.4-4.7 g/dL": 529,
    "530": 530,
    "Transplant Organ": 530,
    "531": 531,
    "Transplant Year": 531,
    "532": 532,
    "Transthoracic Echocardiogram": 532,
    "533": 533,
    "Treatment for SAH": 533,
    "534": 534,
    "Triglycerides, mg/dL": 534,
    "Triglycerides (<150 mg/dL)": 534,
    "535": 535,
    "Troponin (ng/L)": 535,
    "Troponin ng/ml": 535,
    "Troponin (0\u20130.1\u2009ng/ml)": 535,
    "Troponin (<0.01 ng/mL)": 535,
    "Troponin pg/ml": 535,
    "536": 536,
    "Troponin I": 536,
    "Troponin I (ng/L)": 536,
    "Troponin I (ng/mL)": 536,
    "Troponin-I (pg/ml)": 536,
    "537": 537,
    "Troponin T (ng/mL)": 537,
    "Troponin-T": 537,
    "Troponin T, ng/mL": 537,
    "538": 538,
    "Type and duration of symptoms": 538,
    "539": 539,
    "Type of CHD": 539,
    "540": 540,
    "Type of patients with COVID-19 (severe/non-severe)": "COVID-19 disease severity",
    "541": 541,
    "Type of surgery": 541,
    "542": 542,
    "Type of VTE": 542,
    "543": 543,
    "Typical signs of viral infection": "Clinical characteristics",
    "544": 544,
    "Underlying non-pulmonary diseases": "Clinical characteristics",
    "545": 545,
    "Underlying pulmonary diseases": 545,
    "546": 546,
    "Urea (mmol/L)": 546,
    "Urea (mmol/L, 3.6~9.5)": 546,
    "Urea, mg/dl [range: 19\u201344.1]": 546,
    "Urea nitrogen (2.9\u20138.2\u2009mmol /L)": 546,
    "547": 547,
    "Urinary Analyses": 547,
    "Urine analysis": 547,
    "Urine examination": 547,
    "548": 548,
    "Urinary creatinine, mg/dL": 548,
    "549": 549,
    "Urinary dipstick": 549,
    "550": 550,
    "Urinary protein, mg/dL": 550,
    "551": 551,
    "Urinary sodium, mEq/L": 551,
    "552": 552,
    "Urine protein creatinine ratio (mg/g)": "Urinary creatinine, mg/dL",
    "553": 553,
    "Use of corticosteroid": 553,
    "554": 554,
    "Vascular risk factors": "Cardiovascular risk factors",
    "555": 555,
    "Vasopression/inotropy during admission": 555,
    "556": 556,
    "Vasopressors": 556,
    "557": 557,
    "VDRL": 557,
    "558": 558,
    "Ventilated/Critically ill": "Mechanical Ventilator Status",
    "559": 559,
    "Ventilator settings at the time of the event (FiO2%) (PEEP)": "Mechanical Ventilator Status",
    "560": 560,
    "Vessel imaging": 560,
    "561": 561,
    "Viral load CT value (upE gene)": 561,
    "562": 562,
    "Virus": "Clinical characteristics",
    "563": 563,
    "Virus culture": 563,
    "564": 564,
    "Vitamin B12": 564,
    "565": 565,
    "White blood cell count": 565,
    "WBC (*109/l)": 565,
    "WBC (/mmc)": 565,
    "WBC (\u00d7 109/L)": 565,
    "WBC (4.0 \u2013 11.0 k/\u03bcL)": 565,
    "WBC (4.0\u201311.0 K/mm3)": 565,
    "WBC (4.8-10.8 k/mm3)": 565,
    "WBC": 565,
    "White blood cell count (*109/L, 3.5~9.5)": 565,
    "White blood cell count (4.8\u201310.8\u00a0K/\u03bcL)": 565,
    "White blood cell count (4\u201310\u2009\u00d7\u2009109/L)": 565,
    "White blood cell count, k/\u03bcL": 565,
    "White blood cells (WBC)": 565,
    "White blood cells count (4.0\u201311.0 \u00d7 109/L)": 565,
    "White blood count (3.6\u20139.5\u00a0\u200bK/\u03bcL)": 565,
    "White cell count (/mm3)": 565,
    "White cell count (\u00d7109 L)": 565,
    "White cell count (109/L)": 565,
    "White cell count (4.0 \u2013 11.0 x 109/L)": 565,
    "White cell count (K/mm3)": 565,
    "White-cell count (per mm3)": 565,
    "WBC (K/mm3)": 565,
    "WBC (normal 3.12\u20138.44 x 1000/\u03bcL)": 565,
    "WBC \u00d71000/\u03bcL 4.4\u201311": 565,
    "WBC \u00d7103\u00a0cells/\u03bcL": 565,
    "WBC 10^9/l": 565,
    "WBC Count": 565,
    "WBC Count (\u00d7 1000/\u00b5L)": 565,
    "WBC count, \u00d7 109/l": 565,
    "WBC count,\u00a0\u00d7 103/\u03bcL": 565,
    "WBCs (3.9\u201311.0) 10^9/L": 565,
    "White blood cell (/mL)": 565,
    "White blood cell (\u00d7\u2009109/L)": 565,
    "White blood cell (x103/\u03bcL)": 565,
    "566": 566,
    "Weight (kg)": "BMI",
    "Weight, kg": 566,
    "Body weight, kg": 566,
    "567": 567,
    "\u03b3-Glutamyltransferase, U/L": 567
}